Density and distribution of connexin 43 in corpus cavernosum tissue from diabetic and hypogonadal patients with erectile dysfunction
-
Abdulmaged M. Traish
,
Casey Stottrup
Abstract
Aim: Altered expression of connexin 43 (Cx43) has been postulated to be involved in the development and progression of various diseases including erectile dysfunction (ED). The aim of this study was to determine whether distribution and density of the gap junction protein Cx43 are altered in human corpus cavernosum (HCC) tissue samples derived from diabetic or hypogonadal patients with ED compared to those from normal subjects.
Methods: HCC tissue sections derived from normal, diabetic and hypogonadal subjects were fixed in 4% formaldehyde, embedded in paraffin and immunostained with a monoclonal mouse anti-rat Cx43 antibody. Cx43 density was expressed as the cumulative number of gap junction plaques per unit area of tissue corrected for number of 4′,6-diamidino-2-phenylindole, dihydrochloride-labeled smooth muscle cells (dots per unit area corrected for number of cells).
Results: The distribution of Cx43 plaques in smooth muscle was not affected in tissues derived from diabetic or hypogonadal subjects with ED compared with those from normal subjects. However, the number of Cx43 plaques was significantly reduced in HCC tissues derived from diabetic or hypogonadal subjects (73±8% and 68±11% of normal, respectively), indicating reduced Cx43 gap junctions in diabetic and hypogonadal subjects with ED.
Conclusions: Cx43 density in the HCC was diminished in tissue samples derived from diabetic or hypogonadal patients with ED compared to tissue samples from normal non-diabetic subjects. This marked decrease in Cx43 gap junction channels may contribute to attenuated gap junction function and to diminished erectile physiology.
References
1. Moreland RB, Goldstein II, Kim NN, Traish A. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endocrinol Metab 1999;10:97–104.10.1016/S1043-2760(98)00127-1Search in Google Scholar
2. Traish AM, Park K, Dhir V, Kim NN, Moreland RB, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 1999;140:1861–8.10.1210/endo.140.4.6655Search in Google Scholar
3. Traish AM, Toselli P, Jeong SJ, Kim NN. Adipocyte accumulation in penile corpus cavernosum of the orchidectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl 2005;26:242–8.10.1002/j.1939-4640.2005.tb01091.xSearch in Google Scholar
4. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006;3:382–404.10.1111/j.1743-6109.2006.00245.xSearch in Google Scholar
5. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997;20:323–34.10.1046/j.1365-2605.1998.00081.xSearch in Google Scholar
6. Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein I. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol 1997;158:1752–8.10.1016/S0022-5347(01)64118-1Search in Google Scholar
7. Lue T, Goldstein I, Traish A. Comparison of oral and intracavernosal vasoactive agents in penile erection. Int J Impot Res 2000;12(Suppl 1):S81–8.10.1038/sj.ijir.3900503Search in Google Scholar
8. McAuley IW, Kim NN, Min K, Goldstein I, Traish AM. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway. J Androl 2001;22:623–8.Search in Google Scholar
9. Brugger N, Kim NN, Araldi GL, Traish AM, Palmer SS. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. J Sex Med 2008;5:344–56.10.1111/j.1743-6109.2007.00676.xSearch in Google Scholar PubMed
10. Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K, Munarriz R, Lee SW. Pharmacotherapy for erectile dysfunction. J Sex Med 2010;7:524–40.10.1111/j.1743-6109.2009.01627.xSearch in Google Scholar PubMed
11. Pointis G. Connexin43: emerging role in erectile function. Int J Biochem Cell Biol 2006;38:1642–6.10.1016/j.biocel.2006.03.007Search in Google Scholar PubMed
12. Montorsi F, Guazzoni G, Bergamaschi F, Dodesini A, Rigatti P, Pizzini G, Miani A. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology 1993;42:554–8.10.1016/0090-4295(93)90272-CSearch in Google Scholar
13. Serels S, Day NS, Wen YP, Giraldi A, Lee SW, Melman A, Christ GJ. Molecular studies of human connexin 43 (Cx43) expression in isolated corporal tissue strips and cultured corporal smooth muscle cells. Int J Impot Res 1998;10:135–4310.1038/sj.ijir.3900336Search in Google Scholar
14. Christ GJ, Brink PR. Analysis of the presence and physiological relevance of subconducting states of connexin43-derived gap junction channels in cultured human corporal vascular smooth muscle cells. Circ Res 1999;84:797–803.10.1161/01.RES.84.7.797Search in Google Scholar
15. Wang HZ, Day N, Valcic M, Hsieh K, Serels S, Brink PR, Christ GJ. Intercellular communication in cultured human vascular smooth muscle cells. Am J Physiol Cell Physiol 2001;281:C75–88.10.1152/ajpcell.2001.281.1.C75Search in Google Scholar
16. Figueroa XF, Duling BR. Gap junctions in the control of vascular function. Antioxid Redox Signal 2009;11:251–66.10.1089/ars.2008.2117Search in Google Scholar
17. Brink PR, Valiunas V, Wang HZ, Zhao W, Davies K, Christ GJ. Experimental diabetes alters connexin43 derived gap junction permeability in short-term cultures of rat corporeal vascular smooth muscle cells. J Urol 2006;175:381–6.10.1016/S0022-5347(05)00007-8Search in Google Scholar
18. Howarth FC, Chandler NJ, Kharche S, Tellez JO, Greener ID, Yamanushi TT, Billeter R, Boyett MR, Zhang H, Dobrzynski H. Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle. Mol Cell Biochem 2008;319:105–14.10.1007/s11010-008-9883-5Search in Google Scholar PubMed
19. Sheu JJ, Tsai TH, Chang LT, Chiang CH, Youssef AA, Sun CK, Chang NK, Yip HK. Diabetes mellitus down-regulates expression of connexin43 in rat aortic medial smooth muscle cells and can be reversed by simvastatin and losartan therapy. Chang Gung Med J 2008;31:136–44.Search in Google Scholar
20. Mitasíková M, Lin H, Soukup T, Imanaga I, Tribulová N. Diabetes and thyroid hormones affect connexin-43 and PKC-ε expression in rat heart atria. Physiol Res 2009;58:211–7.10.33549/physiolres.931425Search in Google Scholar PubMed
21. Wright JA, Richards T, Becker DL. Connexins and diabetes. Cardiol Res Pract 2012;2012:496904.10.1155/2012/496904Search in Google Scholar PubMed PubMed Central
22. Pessina MA, Hoyt RF, Jr, Goldstein I, Traish AM. Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity. Endocrinology 2006;147:61–9.10.1210/en.2005-0870Search in Google Scholar PubMed
23. Melman A, Christ GJ. Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am 2001;28:217–31.10.1016/S0094-0143(05)70133-6Search in Google Scholar
24. Suadicani SO, Urban-Maldonado M, Tar MT, Melman A, Spray DC. Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int 2009;103: 1686–93.10.1111/j.1464-410X.2008.08337.xSearch in Google Scholar PubMed PubMed Central
25. Bravo-Moreno JF, Díaz-Sánchez V, Montoya-Flores JG, Lamoyi E, Saéz JC, Pérez-Armendariz EM. Expression of connexin43 in mouse Leydig, Sertoli, and germinal cells at different stages of postnatal development. Anat Rec 2001;264:13–24.10.1002/ar.1100Search in Google Scholar PubMed
26. Cyr DG, Hermo L, Laird DW. Immunocytochemical localization and regulation of connexin43 in the adult rat epididymis. Endocrinology 1996;137:1474–84.10.1210/endo.137.4.8625926Search in Google Scholar PubMed
27. Izzo G, Ferrara D, Delrio G, d’Istria M, Minucci S. Connexin43 expression in the testis of frog Rana esculenta: sex hormonal regulation. Ann NY Acad Sci 2009;1163:425–7.10.1111/j.1749-6632.2008.03651.xSearch in Google Scholar PubMed
28. Mitra S, Annamalai L, Chakraborty S, Johnson K, Song XH, Batra SK, Mehta PP. Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Mol Biol Cell 2006;17:5400–16.10.1091/mbc.e06-04-0280Search in Google Scholar PubMed PubMed Central
©2013 by Walter de Gruyter Berlin Boston
Articles in the same Issue
- Masthead
- Masthead
- Mini Review
- Steroids in semen, their role in spermatogenesis, and the possible impact of endocrine disruptors
- Original Article
- Density and distribution of connexin 43 in corpus cavernosum tissue from diabetic and hypogonadal patients with erectile dysfunction
Articles in the same Issue
- Masthead
- Masthead
- Mini Review
- Steroids in semen, their role in spermatogenesis, and the possible impact of endocrine disruptors
- Original Article
- Density and distribution of connexin 43 in corpus cavernosum tissue from diabetic and hypogonadal patients with erectile dysfunction
